New inhaled drug aims to keep bronchiectasis patients Flare-Up free
NCT ID NCT07048262
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an inhaled medicine called CSL787 in adults with non-cystic fibrosis bronchiectasis, a lung condition that causes frequent infections and breathing problems. The goal is to see if CSL787 can delay the time until a person's next lung flare-up (exacerbation) compared to a placebo. About 450 adults aged 18 to 85 will take part, receiving either one of two doses of CSL787 or a placebo via a nebulizer for up to 12 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-CYSTIC FIBROSIS BRONCHIECTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fukuoka University Chikushi Hopsital
RECRUITINGChikushino-shi, Japan
-
Ibaraki Prefectural Central Hospital
RECRUITINGIbaraki, Japan
-
Japan Anti-Tuberculosis Association, Fukujuji Hospital
RECRUITINGTokyo, Japan
-
Kazunori Tobino Iizuka Hospital
RECRUITINGIizuka-shi, Japan
-
Keio University Hospital
RECRUITINGTokyo, Japan
-
Kyusho Central Hospital of the Mutual Aid Association of Public School Teachers
RECRUITINGFukuoka, Japan
-
Matsusaka Municipal Hospital
RECRUITINGMie, Japan
-
National Hospital Organization Kinki Chuo Chest Medical Center
RECRUITINGOsaka, Japan
-
National Hospital Organization Mie Chuo Medical Center
RECRUITINGTsu, Japan
-
National Hospital Organization Minami Kyoto Hospital
RECRUITINGKyoto, Japan
-
Shimonoseki City Hospital
RECRUITINGShimonoseki-shi, Japan
-
The Prince Charles Hospital
RECRUITINGQueensland, Australia
-
Westmead Hospital
RECRUITINGWestmead, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A vibrating vest may help children with damaged lungs breathe easier
- Can a new biologic drug delay dangerous lung Flare-Ups?
- Inhaled experimental drug targets tough lung infections
- New drug trial aims to tame chronic lung infections
- Scientists develop risk score to forecast bronchiectasis attacks
- 500 patients to test if daily azithromycin keeps bronchiectasis attacks at bay